Elevated tricuspid regurgitation velocity in congenital hemolytic anemias: Prevalence and laboratory correlates
- 25 March 2019
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 66 (7), e27717
- https://doi.org/10.1002/pbc.27717
Abstract
Elevated tricuspid valve regurgitation jet velocity (TRV ≥ 2.5 m/s) is associated with mortality among adults with sickle cell disease (SCD), but correlative biomarkers are not studied according to treatment exposure or genotypes. To investigate the associations between biomarkers and TRV elevation, we examined the relationship between TRV and hemolytic, inflammatory, and cardiac biomarkers, stratified by disease‐modifying treatments and SCD genotype. In total, 294 participants with SCD (mean age, 11.0 ± 3.7 years) and 49 hereditary spherocytosis (HS; mean age, 22.9 ± 19.75 years) were included for comparison and enrolled. TRV was elevated in 30.7% of children with SCD overall: 18.8% in HbSC/HbSβ+‐thalassemia, 28.9% in untreated HbSS/HbSβ0‐thalassemia, 34.2% in HbSS/HbSβ0‐thalassemia hydroxyurea‐treated, and 57% in HbSS/HbSβ0‐thalassemia chronic transfusion treated. TRV was elevated in 10.7% and 27.8% in HS children and adults, respectively. In children with SCD, elevated TRV was correlated with hemoglobin (odds ratio [OR] = 0.78, P = 0.004), lactate dehydrogenase (LDH; OR = 2.52, P = 0.005), and N‐terminal pro‐brain natriuretic peptide (NT‐pro BNP; OR = 1.003, P = 0.004). In multivariable logistic regression, adjusting for genotype, sex, hemolytic index, and treatment, hemoglobin concentration remained the only significant variable associated with elevated TRV in untreated HbSS/HbSβ0‐thalassemia participants. TRV was not associated with inflammatory markers, other markers of hemolysis, or NT‐pro BNP in untreated HbSS/HbSβ0‐thalassemia. Neither hemoglobin nor LDH was associated with TRV in HbSC/HbSβ+‐thalassemia. These results suggest that elevated TRV is influenced by the degree of anemia, possibly reflecting sickling as part of the disease pathophysiology. Prospective studies should monitor hemoglobin concentration as children with SCD age into adulthood, prompting initiation of TRV screening and monitoring.This publication has 44 references indexed in Scilit:
- Risk Factors for Death in 632 Patients with Sickle Cell Disease in the United States and United KingdomPLOS ONE, 2014
- Pulmonary Artery Occlusion Pressure May Overdiagnose Pulmonary Artery Hypertension in Sickle Cell DiseaseClinical Cardiology, 2013
- Misclassification of Pulmonary Hypertension in Adults with Sickle Hemoglobinopathies Using Doppler EchocardiographySouthern Medical Journal, 2012
- Markers of Severe Vaso-Occlusive Painful Episode Frequency in Children and Adolescents with Sickle Cell AnemiaThe Journal of Pediatrics, 2012
- Proteinuria is associated with elevated tricuspid regurgitant jet velocity in children with sickle cell diseasePediatric Blood & Cancer, 2011
- A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell DiseaseThe New England Journal of Medicine, 2011
- Doppler‐defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three yearsBritish Journal of Haematology, 2009
- Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturationHaematologica, 2009
- Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell DiseaseThe New England Journal of Medicine, 2004
- Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survivalBlood, 2003